Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Accumulated Expenses (2016 - 2025)

Conmed (CNMD) has disclosed Accumulated Expenses for 16 consecutive years, with $82.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 25.66% year-over-year to $82.1 million, compared with a TTM value of $82.1 million through Dec 2025, up 25.66%, and an annual FY2025 reading of $82.1 million, up 25.66% over the prior year.
  • Accumulated Expenses was $82.1 million for Q4 2025 at Conmed, up from $76.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $82.1 million in Q4 2025 and bottomed at $40.9 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $58.0 million, with a median of $55.2 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses surged 33.59% in 2021, then decreased 9.51% in 2022.
  • Year by year, Accumulated Expenses stood at $60.5 million in 2021, then dropped by 9.51% to $54.7 million in 2022, then rose by 28.02% to $70.1 million in 2023, then dropped by 6.71% to $65.4 million in 2024, then grew by 25.66% to $82.1 million in 2025.
  • Business Quant data shows Accumulated Expenses for CNMD at $82.1 million in Q4 2025, $76.1 million in Q3 2025, and $67.9 million in Q2 2025.